Back

A panel of experts discusses use of antithrombotic therapy for treatment of polyvascular disease, in particular coronary artery disease (CAD). They also share data in patients with CAD and peripheral artery disease (PAD) with dual pathway inhibition (DPI) and their insights on optimal duration of dual antiplatelet therapy (DAPT) and rationale for switching therapy.

Expert Perspectives on Managing Polyvascular Disease and Coronary Artery Disease

Episodes

Specialty:

All

Year:

All

EP. 1: Overview of Polyvascular Disease and Coronary Artery Disease

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

April 29th 2022

Drs Marc Bonaca and Manesh Patel provide an overview of Polyvascular Disease and prevalence of coronary artery disease and peripheral artery disease.

EP. 2: Screening for Polyvascular Disease

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

April 29th 2022

Dr Amy Pollak and other experts discuss their recommendations for screening for CAD and PAD in asymptomatic patients.

EP. 3: Provider Engagement and Screening

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

May 6th 2022

Dr Sahil Parikh and other experts discuss engagement of cardiologists in patients diagnosed with polyvascular disease and challenges in screening patients.

EP. 4: Guidelines and Management of Patients With Polyvascular Disease

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

May 6th 2022

Expert cardiologists discuss CAD guidelines and approaches to management of patients with polyvascular disease.

EP. 5: Dual Antiplatelet Therapy in CAD

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

May 13th 2022

Dr Manesh Patel and other experts discuss the role of dual antiplatelet therapy (DAPT) in treatment of coronary artery disease.

EP. 6: Regimen Intensification in Polyvascular Disease

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

May 13th 2022

Drs Marc Bonaca and Deepak Bhatt discuss the role of therapy intensification when managing high-risk patients with polyvascular disease.

EP. 7: Stents in Treatment of CAD and PAD

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

May 20th 2022

Dr Eric Secemsky discusses how use of stents has evolved over the years in treatment of polyvascular disease.

EP. 8: Risk-Benefit Analysis in Treatment Selection in CAD

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

May 20th 2022

Dr Amy Pollak shares her thoughts on risk-benefit analysis when evaluating patients with high thrombotic/bleeding risk and treatment selection.

EP. 9: Dual Pathway Inhibition in Coronary Artery Disease

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

May 27th 2022

Expert cardiologists provide an overview of dual pathway inhibition, modulation of thrombotic risk and treatment of CAD.

EP. 10: Direct Oral Anticoagulants and Dosing

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

May 27th 2022

Drs Patel and Bhatt discuss importance of correct dosing of direct oral anticoagulants in treatment of cardiovascular diseases.

EP. 11: Access to and Awareness of DPI for Polyvascular Disease

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

June 3rd 2022

Sahil Parikh, MD, shares how lack of access to or awareness of DPI [dual pathway inhibition] causes many practices and health care providers to face a challenge in treating CAD [coronary artery disease].

EP. 12: COMPASS Trial for CAD and PAD

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

June 3rd 2022

Expert cardiologists discuss data from COMPASS trial and the role of rivaroxaban and low-dose aspirin in treatment of patients with CAD and PAD.

EP. 13: VOYAGER Trial and DPI in Clinical Practice

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

June 10th 2022

Manesh Patel, MD, reviews VOYAGER trial data and expert cardiologists share where they use DPI [dual pathway inhibition] in their practices.

EP. 14: Unmet Needs and Emerging Approaches to Management of Polyvascular Disease

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

June 10th 2022

Cardiologists share unmet needs and emerging approaches to management of patients with polyvascular disease.

EP. 15: Concluding Thoughts

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

June 10th 2022

A panel of expert cardiologists share their concluding thoughts on management of polyvascular disease in clinical practice.

Expert Perspectives on Managing Polyvascular Disease and Coronary Artery Disease

Episodes

EP. 1: Overview of Polyvascular Disease and Coronary Artery Disease

EP. 2: Screening for Polyvascular Disease

EP. 3: Provider Engagement and Screening

EP. 4: Guidelines and Management of Patients With Polyvascular Disease

EP. 5: Dual Antiplatelet Therapy in CAD

EP. 6: Regimen Intensification in Polyvascular Disease

EP. 7: Stents in Treatment of CAD and PAD

EP. 8: Risk-Benefit Analysis in Treatment Selection in CAD

EP. 9: Dual Pathway Inhibition in Coronary Artery Disease

EP. 10: Direct Oral Anticoagulants and Dosing

EP. 11: Access to and Awareness of DPI for Polyvascular Disease

EP. 12: COMPASS Trial for CAD and PAD

EP. 13: VOYAGER Trial and DPI in Clinical Practice

EP. 14: Unmet Needs and Emerging Approaches to Management of Polyvascular Disease

EP. 15: Concluding Thoughts

Trending on HCPLive

Optimizing IBD Treatment and Sequencing, With Jordan Axelrad, MD, MPH

Sugar-Sweetened Beverages Associated With Increased Gastric Cancer Risk, With Andrew Chan, MD, MPH

Avexitide Reduces Hypoglycemic Events in Phase 3 LUCIDITY Trial for PBH

Metabolic Dysfunction May Explain Sugar-Sweetened Beverage–Gastric Cancer Link, With Andrew Chan, MD, MPH

Ketamine, Psychedelics Share Neuroimmune Signature in TRD